Across TCGA pan-cancer cohorts, OR51P1P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR51P1P data layer.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher OR51P1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR51P1P expression acts as an unfavorable survival marker.
DLBC, STAD, and SARC are the cancer types where OR51P1P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.